Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...
Nov. 12. 2025 — The American Heart Association’s Council on Clinical Cardiology has selected Roxana Mehran, MD, as the ...
Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...
Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...
Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...
Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 10, 2025 — Kestra Medical Technologies, a wearable medical device and digital healthcare company, has announced ...
Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...
Nov. 8, 2025 — Sanjay Rajagopalan, MD, MBA, Chief of Cardiovascular Medicine at University Hospitals Harrington Heart & ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...
Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease ...
Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...
November 14, 2025
